Diabetic macular edema is a major cause of vision loss in diabetes. It occurs when leaky retinal vessels cause swelling in the macula, the central area responsible for sharp vision.

DME can develop at any stage of diabetic retinopathy and varies in severity. We use Optical Coherence Tomography (OCT) to detect even subtle macular thickening. Early detection is key for effective treatment.

Most patients benefit from intravitreal injections of anti-VEGF medications such as:

• Eylea® (Aflibercept)
• Eylea HD® (Aflibercept)
• Avastin® (Bevacizumab)
• VABYSMO® (Faricimab)
• Lucentis® (Ranibizumab)

Steroid implants may also be used in some cases:

• Ozurdex® (Dexamethasone)
• Iluvien® (Fluocinolone Acetonide)

These treatments help reduce swelling and stabilize vision, though they may not restore vision already lost.